Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
Titel:
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
Auteur:
Georgoulias, Vassilis Androulakis, Nikolaos Kotsakis, Athanasios Hatzidaki, Dora Syrigos, Kostas Polyzos, Aris Agelidou, Athina Varthalitis, Ioannis Ziras, Nikoalos Agelidou, Maria Chandrinos, Vassilis Boukovinas, Ioannis Geroyianni, Alexandra Vamvakas, Lambros Mavroudis, Dimitris